Fiona Havers1, Laura Smeaton2, Nikhil Gupte3, Barbara Detrick4, Robert C Bollinger5, James Hakim6, Nagalingeswaran Kumarasamy7, Adriana Andrade1, Parul Christian2, Javier R Lama8, Thomas B Campbell9, Amita Gupta5. 1. Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Bloomberg School of Public Health, Johns Hopkins University. 3. Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland HIV Clinical Trials Unit, B.J. Medical College, Pune, India. 4. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland Bloomberg School of Public Health, Johns Hopkins University HIV Clinical Trials Unit, B.J. Medical College, Pune, India. 6. Department of Medicine, University of Zimbabwe, Harare, Zimbabwe. 7. YRGCARE Medical Centre, Chennai, India. 8. IMPACTA PERU Clinical Trials Unit, Asociacion Civil Impacta Salud y Educacion, Lima, Peru. 9. Division of Infectious Diseases, University of Colorado Denver, Aurora.
Abstract
BACKGROUND:Low 25-hydroxyvitamin D (25(OH)D) has been associated with increased HIV mortality, but prospective studies assessing treatment outcomes after combination antiretroviral therapy (cART) initiation in resource-limited settings are lacking. METHODS: A case-cohort study (N = 411) was nested within a randomized cART trial of 1571 cART-naive adults in 8 resource-limited settings and the United States. The primary outcome (WHO stage 3/4 disease or death within 96 weeks of cART initiation) was met by 192 cases, and 152 and 29 cases met secondary outcomes of virologic and immunologic failure. We studied prevalence and risk factors for baseline low 25(OH)D (<32 ng/mL) and examined associated outcomes using proportional hazard models. RESULTS:Low 25(OH)D prevalence was 49% and ranged from 27% in Brazil to 78% in Thailand. Low 25(OH)D was associated with high body mass index (BMI), winter/spring season, country-race group, and lower viral load. Baseline low 25(OH)D was associated with increased risk of human immunodeficiency virus (HIV) progression and death (adjusted hazard ratio (aHR) 2.13; 95% confidence interval [CI], 1.09-4.18) and virologic failure (aHR 2.42; 95% CI, 1.33-4.41). CONCLUSIONS: Low 25(OH)D is common in diverse HIV-infected populations and is an independent risk factor for clinical and virologic failure. Studies examining the potential benefit of vitamin D supplementation among HIV patients initiating cART are warranted.
RCT Entities:
BACKGROUND: Low 25-hydroxyvitamin D (25(OH)D) has been associated with increased HIV mortality, but prospective studies assessing treatment outcomes after combination antiretroviral therapy (cART) initiation in resource-limited settings are lacking. METHODS: A case-cohort study (N = 411) was nested within a randomized cART trial of 1571 cART-naive adults in 8 resource-limited settings and the United States. The primary outcome (WHO stage 3/4 disease or death within 96 weeks of cART initiation) was met by 192 cases, and 152 and 29 cases met secondary outcomes of virologic and immunologic failure. We studied prevalence and risk factors for baseline low 25(OH)D (<32 ng/mL) and examined associated outcomes using proportional hazard models. RESULTS: Low 25(OH)D prevalence was 49% and ranged from 27% in Brazil to 78% in Thailand. Low 25(OH)D was associated with high body mass index (BMI), winter/spring season, country-race group, and lower viral load. Baseline low 25(OH)D was associated with increased risk of human immunodeficiency virus (HIV) progression and death (adjusted hazard ratio (aHR) 2.13; 95% confidence interval [CI], 1.09-4.18) and virologic failure (aHR 2.42; 95% CI, 1.33-4.41). CONCLUSIONS: Low 25(OH)D is common in diverse HIV-infected populations and is an independent risk factor for clinical and virologic failure. Studies examining the potential benefit of vitamin D supplementation among HIVpatients initiating cART are warranted.
Authors: Mattias Mandorfer; Thomas Reiberger; Berit A Payer; Arnulf Ferlitsch; Florian Breitenecker; Maximilian C Aichelburg; Barbara Obermayer-Pietsch; Armin Rieger; Michael Trauner; Markus Peck-Radosavljevic Journal: AIDS Date: 2013-01-14 Impact factor: 4.177
Authors: Christopher R Sudfeld; Edward L Giovannucci; Sheila Isanaka; Said Aboud; Ferdinand M Mugusi; Molin Wang; Guerino Chalamilla; Wafaie W Fawzi Journal: J Infect Dis Date: 2012-11-16 Impact factor: 5.226
Authors: Thomas B Campbell; Laura M Smeaton; N Kumarasamy; Timothy Flanigan; Karin L Klingman; Cynthia Firnhaber; Beatriz Grinsztejn; Mina C Hosseinipour; Johnstone Kumwenda; Umesh Lalloo; Cynthia Riviere; Jorge Sanchez; Marineide Melo; Khuanchai Supparatpinyo; Srikanth Tripathy; Ana I Martinez; Apsara Nair; Ann Walawander; Laura Moran; Yun Chen; Wendy Snowden; James F Rooney; Jonathan Uy; Robert T Schooley; Victor De Gruttola; James Gita Hakim Journal: PLoS Med Date: 2012-08-14 Impact factor: 11.069
Authors: Rupak Shivakoti; Erin R Ewald; Nikhil Gupte; Wei-Teng Yang; Cecilia Kanyama; Sandra W Cardoso; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Richard Pollard; Barbara Detrick; Ashwin Balagopal; David M Asmuth; Richard D Semba; Thomas B Campbell; Jonathan Golub; Amita Gupta Journal: Clin Nutr Date: 2018-05-29 Impact factor: 7.324
Authors: Christopher R Sudfeld; Ferdinand Mugusi; Alfa Muhihi; Said Aboud; Tumaini J Nagu; Nzovu Ulenga; Biling Hong; Molin Wang; Wafaie W Fawzi Journal: Lancet HIV Date: 2020-07 Impact factor: 12.767
Authors: A Calcagno; S Nozza; C Muss; B M Celesia; F Carli; S Piconi; G V De Socio; A M Cattelan; G Orofino; D Ripamonti; A Riva; G Di Perri Journal: Infection Date: 2015-05-19 Impact factor: 3.553
Authors: H Melliez; A Duhamel; O Robineau; L Bocket; I Kim; E Sauser; F Loiseleur; N Viget; A Pasquet; E Senneville; D Seguy Journal: Eur J Clin Microbiol Infect Dis Date: 2017-06-24 Impact factor: 3.267
Authors: Panagiotis Dragonas; Linda M Kaste; Martha Nunn; Praveen K Gajendrareddy; Kathleen M Weber; Mardge Cohen; Oluwatoyin M Adeyemi; Audrey L French; Herve Y Sroussi Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2018-02-19